Source: Annual Congress 2013 –Oncological thoracic surgery
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Woolnough, M. Kalkat, H. Kunst (Birmingham, United Kingdom). Predictive value of pre-test clinical diagnosis for mediastinal lymphadenopathy compared to histological outcomes from cervical mediastinoscopy. Eur Respir J 2013; 42: Suppl. 57, 454

Member's Comments

No comment yet.

Related content which might interest you: EBUS in real life: Primary diagnosis and mediastinal staging Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Diagnostic value of cervical mediastinoscopy: Report of 506 cases Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 The role of number of lymph node passes and methods of pathological examination in the adequacy specimens of EBUS-TBNA in the verification of mediastinal lymphadenopathy Source: Annual Congress 2013 –VATS, interventional endoscopy and tracheal surgery Year: 2013 Improved negative predictive value of EBUS-TBNA in isolated mediastinal / hilar lymphadenopathy: Why and what it means for patients? Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy Year: 2013 Efficacy of conventional TBNA in patients with mediastinal adenopathies - A role of cytopathologist Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques Year: 2015 No additional diagnostic gain of mediastinoscopy following sytematically and thouroughly performed mediastinal staging by EBUS-TBNA Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall Year: 2014 Determinants of negative predictive value during EBUS-TBNA in diagnosis/staging of lung cancer Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Clinical and radiological predictors of post-procedure pneumothorax complicating CT-guided lung biopsy Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Features predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound in Indian setting: Is it different? Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Utility of EUS-B-FNA for the diagnosis of EBUS-TBNA inaccessible intrathoracic lesions Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Incidence of malignancy in patients with pleural effusion referred for workup by pulmonologists: Diagnostic yield of thoracentesis, and use of other investigational procedures Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 PET-CT predictors of mediastinal dissemination in lung cancer Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery Year: 2014 A rare diagnosis after pediatric tuberculosis screening Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Elastography strain ratio in the staging of mediastinal lymph nodes Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall Year: 2014 EBUS-TBNA in the diagnosis of haematological malignancies; overcoming the challenge Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 EBUS TBNA negative lymph nodes risk stratification model: A tool for multidisciplinary team Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery Year: 2015 Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013